0% Complete
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
HLA Class I Alleles as prognostic marker in Hepatocellular Carcinoma
نویسندگان :
Shahram Aliyari
1
Zahra Salehi
2
Mohammad Hossein Norouzi-Beirami
3
Kaveh Kavousi
4
1- Department of Bioinformatics, Kish International Campus University of Tehran, Kish, Iran. 2 Institute of Biochemistry and Biophysics (IBB), Department of Bioinformatics, Laboratory of Complex Biological
2- Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Tehran, Iran
3- Department of Computer Engineering, Osku Branch, Islamic Azad University, Osku, Iran
4- 2 Institute of Biochemistry and Biophysics (IBB), Department of Bioinformatics, Laboratory of Complex Biological Systems and Bioinformatics (CBB), University of Tehran, Tehran, Iran.
کلمات کلیدی :
Hepatocellular carcinoma،Human Leukocyte Antigen،Prognostic factors،Bioinformatics
چکیده :
Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide, accounting for a significant portion of cancer-related deaths. Its aggressive nature, late diagnosis, and resistance to conventional therapies contribute to poor clinical outcomes. Immune evasion, a hallmark of cancer progression, plays a pivotal role in HCC, allowing tumor cells to escape immune surveillance and establish a favorable microenvironment for growth and metastasis. Human Leukocyte Antigen (HLA) Class I molecules are critical components of the immune system that mediate tumor-immune interactions by presenting tumor-derived antigens to cytotoxic T lymphocytes (CTLs). Disruptions in HLA expression or allele-specific variations can impair antigen presentation, reducing immune recognition and facilitating tumor immune escape. Despite this central role, the specific impact of HLA Class I alleles on HCC progression, prognosis, and therapeutic response remains underexplored. A deeper understanding of the relationship between HLA-I alleles and HCC could reveal novel immunogenomic biomarkers for both prognosis and therapeutic intervention. To address this knowledge gap, we conducted a comprehensive analysis of HLA Class I alleles in HCC patients using data from The Cancer Genome Atlas (TCGA). Our dataset comprised 8,998 samples, including patients with HCC and a pan-cancer cohort. We investigated allele frequency disparities across these groups to identify HLA-I alleles with potential prognostic significance. Statistical analyses were performed using Fisher's exact test to determine the significance of allele frequency differences, providing insights into their association with HCC development and clinical outcomes. Several HLA Class I alleles were identified as significantly associated with an increased risk of HCC, including A11:01, A33:03, B46:01, C01:02, C07:06, and C08:01. These alleles demonstrated higher frequencies in HCC patients compared to the pan-cancer cohort, suggesting their role in disease susceptibility. Notably, HLA-B*51:01 exhibited a significant correlation with improved survival outcomes (Log HR -0.769, p-value 0.035), highlighting its potential as a prognostic biomarker. However, the prognostic relevance of other identified alleles remains unclear and requires further validation through detailed survival analyses. This study highlights the importance of HLA Class I alleles in HCC, revealing their association with disease risk and survival outcomes. These findings suggest that specific HLA-I alleles may serve as valuable immunogenomic biomarkers for prognosis, paving the way for tailored therapeutic strategies, including personalized immunotherapy approaches. Future studies are warranted to further elucidate the functional mechanisms underlying these associations and their clinical utility. Keywords: Hepatocellular carcinoma, Human Leukocyte Antigen, Prognostic factors, Bioinformatics
لیست مقالات
لیست مقالات بایگانی شده
In silico vaccine design for breast cancer
Zohre Sadeghi - Zahra Davoudi
In Silico Design of DNA G-Quadruplex Aptamers Targeting Lipopolysaccharide Core and Capsular Polysaccharide in Multidrug-Resistant Klebsiella pneumoniae
Aida Arezoumandchafi - Maryam Azimzadeh Irani - Hamidreza Mollasalehi
Exploring the interaction between hsa-miR-122-5p and CDC25A gene in Breast carcinoma progression via computational analysis
Sara Seyed Shazileh
Iron, Oxidative Stress, and Skin Aging: The Therapeutic Potential of TGF-β1 Modulation
Maryam Kaboli - Amir Amiri-Yekta - Seyed Abolhassan Shahzadeh Fazeli - Yasser Tahamtani
Structural and Hydrogen Bonding Characteristics of Natural Deep Eutectic Solvent Choline Chloride/Citric Acid: A Molecular Dynamics Simulation Study
Faezeh Saadatnia - Delara Mohammadaghaie - Fatemeh Mohammadpour - Samane Boromand
Uncovering Disrupted Cell-Cell Interactions in Alzheimer's Disease Using Variational Graph Autoencoders on Single-Cell Spatial Transcriptomics Data from the Human Middle Temporal Gyrus
Zahra Bayat - Alireza Fotuhi Siahpirani
Bioinformatic Approach to Predict the Regulatory Mechanisms: TF–miRNA–mRNA–lncRNA Network during Cluster Development in Grape
Shahla Sahraei - Nafiseh Mahdinezhad - Abbasali Emamjomeh - Kaveh Kavousi - Mahmood Solouki - Massimo Delledonne
"Molecular Docking Study of Natural Compounds from Daucus carota as Inhibitors of VEGFR-2: A Computational Approach for Drug Design"
MohammadMoein Bashi Mehrizi - Seyed Mohammad Mahdi Mortazavian - Hossein Hadavand Mirzaei
The Regulatory Role of DNA Methylation in Age-Related Macular Degeneration (AMD)
Shohreh Yazdani - Alireza Fotuhi Siahpirani
Integrating Biological Networks and Deep Learning for Microbe-Disease Prediction
Sobhan Ahmadian Moghadam - Zahra Ghorbanali - Fatemeh Zare-Mirakabad - Hesam Montazeri
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.7.0